C. Michael Gibson

基本信息

Career Trajectory

Bio

Gibson has led phase 1-4 clinical trials, and cardiology megatrials of up to 30,000 patients which eventuated in international approval of drugs like prasugrel, rivaroxaban, betrixaban and andexanet and devices that alert patients to a heart attack.
Gibson has been chosen as one of Boston's Top Doctors & U.S. News & World Report also lists Gibson as one of America's top doctors. Gibson invented measures of coronary blood flow that are widely used today (the TIMI frame count, the TIMI myocardial perfusion grade).

Research Interests

Papers共 1264 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Non-vitamin K Antagonist Oral Anticoagulants (noacs) after Transcatheter Aortic Valve Replacement (TAVR): a Network Meta-Analysis

Samer Al Said,Klaus Kaier,Edris Nury, Dima Alsaid,C Michael Gibson,Jeroen Bax,Dirk Westermann,Joerg J Meerpohl

The Cochrane database of systematic reviews（2025）

Cited0Views0WOSBibtex

Water Hammer Phenomenon in Coronary Arteries: Scientific Basis for Diagnostic and Predictive Modeling with Acoustic Action Mapping

Khiem D Ngo,Thach Nguyen, Huan Dat Pham, Hadrian Tran, Dat Q Ha, Truong S Dinh,Imran Mihas, Mihas Kodenchery,C Michael Gibson,Hien Q Nguyen,Thang Nguyen,Vu T Loc, Chinh D Nguyen,Hoang Anh Tien, Ernest Talarico,Marco Zuin,Gianluca Rigatelli,Aravinda Nanjundappa,Quynh T N Nguyen, The-Hung Nguyen

Diagnostics (Basel, Switzerland)no. 5 (2025)

Cited0Views0WOSBibtex

APOLIPOPROTEIN A-I INFUSIONS AND CARDIOVASCULAR OUTCOMES IN ACUTE MYOCARDIAL INFARCTION ACCORDING TO NEUTROPHIL-LYMPHOCYTE RATIO AND BASELINE LDLCHOLESTEROL LEVELS: INSIGHTS FROM THE AEGIS-II TRIAL

Sem Rikken,C. Michael Gibson, Maria Cecilia Bahit,Danielle Duffy,Gerald Chi,Harvey D. White,Serge Korjian, Gaya Anschuetz, Bronwyn Kingwell, Jose C. Nicolau, Basil S. Lewis,Renato D. Lopes,Dragos Vinereanu,Shaun G. Goodman,Christoph Bode,Philippe Gabriel Steg,Peter Libby,Frank M. Sacks,Kevin R. Bainey,Paul M. Ridker

Journal of the American College of Cardiologyno. 12 (2025): 1848

Cited0Views0Bibtex

Oral Factor Xia Inhibitor Milvexian after a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (librexia ACS)

C Michael Gibson,M Cecilia Bahit,Roxana Mehran,Shamir R Mehta,Rasha Al Lamee,Shinya Goto,Jeffrey I Weitz,Jay Horrow,Elliot S Barnathan,Robert A Harrington,Kenneth W Mahaffey,Carolyn S P Lam,Karen S Pieper,S Claiborne Johnston,Graeme J Hankey,Alexei N Plotnikov,Danshi Li,Hsiaowei Deng,Philippe Gabriel Steg, Librexia ACS Committees and Investigators.

American heart journal (2025): 21-28

Cited0Views0WOSBibtex

APOLIPOPROTEIN A-I INFUSIONS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND MODERATE RENAL IMPAIRMENT: INSIGHTS FROM THE AEGIS-II TRIAL

Gerald Chi,C. Michael Gibson, Maria Cecilia Bahit,Danielle Duffy, Sem Rikken,Jan Hein Cornel,Harvey D. White,Serge Korjian, Gaya Anschuetz, Charles Luo, Jose C. Nicolau,Renato D. Lopes, Basil S. Lewis,Dragos Vinereanu,Shaun G. Goodman,Christoph Bode,Philippe Gabriel Steg,Peter Libby,Frank M. Sacks,Kevin R. Bainey

Journal of the American College of Cardiologyno. 12 (2025): 1735

Cited0Views0Bibtex

UPDATED META-ANALYSIS OF RANDOMIZED TRIALS COMPARING COMPLETE VERSUS CULPRITONLY REVASCULARIZATION IN PATIENTS WITH MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY DISEASE

Hassan Kazmi,Gerald Chi, Himani Jha,Aniruddha Singh, Hamza Hafeez, Brian Daniel McCauley, Michael Macciocca, Julian Diaz Fraga, FARWA ZAHRA, Sameen Raza, Muhammad Mohsin Zafar, Umar Ahmad,Tayyab Ali Waheed, Jane Lee, Sohail Zaidi,C. Michael Gibson

Journal of the American College of Cardiologyno. 12 (2025): 1950

Cited0Views0Bibtex

ACCELERATING CLINICAL DEVELOPMENT TIMELINES AND ENHANCING DATA QUALITY THROUGH ROBUST ENDPOINT IDENTIFICATION PROCESS: INSIGHTS FROM THE AEGIS-II TRIAL

Ines Pagel Langenickel,Venu Menon,Vidyasagar Kalahasti, Stephen Horchler, Christine Shaffer,Danielle Duffy, Keiko Shimamoto, Gaya Anschuetz, Natalya Pelekh, Vonzella Hood, Lynn Perkins,Pierluigi Tricoci,John H. Alexander,C. Michael Gibson

Journal of the American College of Cardiologyno. 12 (2025): 463

Cited0Views0Bibtex

Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial

Wissam A. Jaber, Carin F. Gonsalves,Stefan Stortecky,Samuel Horr, Orestis Pappas,Ripal T. Gandhi,Keith Pereira,Jay Giri,Sameer J. Khandhar, Khawaja Afzal Ammar,David M. Lasorda,Brian Stegman, Lucas Busch,David J. Dexter,Ezana M. Azene, Nikhil Daga,Fakhir Elmasri, Chandra R. Kunavarapu, Mark E. Rea,Joseph S. Rossi, Joseph Campbell,Jonathan Lindquist,Adam Raskin,Jason C. Smith, Thomas M. Tamlyn,Gabriel A. Hernandez,Parth Rali, Torrey R. Schmidt,Jeffrey T. Bruckel,Juan C. Camacho,Jun Li,Samy Selim,Catalin Toma, Sukhdeep Singh Basra,Brian A. Bergmark,Bhavraj Khalsa,David M. Zlotnick,Jordan Castle, David J. O'Connor,C. Michael Gibson

CIRCULATIONno. 5 (2025): 260-273

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 1264 篇Author StatisticsCo-AuthorSimilar Experts